Viser 320 virksomheder for "Pharmaceuticals"
Virksomheder
Novo Nordisk er en global medicinalvirksomhed med fokus på behandling af diabetes, fedme og andre alvorlige kroniske sygdomme. De tilbyder innovative lægemidler og administrationssystemer og indtager en førende position inden for diabetesbehandling. Virksomheden er engageret i bæredygtig udvikling og patientadgang.
Abbott er en global sundhedsteknologivirksomhed, der er engageret i at hjælpe mennesker med at leve mere fuldt ud gennem sundhedens kraft. De tilbyder en diversificeret portefølje af førende, videnskabsbaserede produkter inden for diagnostik, medicinsk udstyr, ernæring og generiske lægemidler med varemærke. Abbott er førende inden for diabetesbehandling med FreeStyle Libre og er dedikeret til at forbedre sundhedsresultaterne på verdensplan.
Abbott er en sundhedsvirksomhed dedikeret til at hjælpe mennesker med at leve sundere liv. De udvikler innovative sundhedsteknologier og -produkter, herunder værktøjer til diabetesbehandling, kardiovaskulære apparater, diagnostik og ernæringsprodukter. Med over 135 års erfaring opererer Abbott i mere end 160 lande og beskæftiger over 114.000 mennesker med det formål at forbedre sundhedsresultater globalt.
Pfizer is a leading biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines and vaccines. The company's portfolio includes a wide range of treatments for areas like oncology, vaccines, and immunology. Pfizer is recognized for its global reach and commitment to improving patient health.
AstraZeneca is a global pharmaceutical company that researches, develops, and commercializes prescription medicines. They focus on therapy areas such as oncology, biopharmaceuticals, and rare diseases. AstraZeneca is known for its science-led approach and commitment to improving health worldwide.
Sanofi is an R&D-driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth. They focus on developing breakthrough innovations in medicines and vaccines, with expertise in immunology, oncology, and rare diseases. The company has a global presence and emphasizes sustainable and equitable access to healthcare. Sanofi strives to pursue the miracles of science so people can chase their dreams.
Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies. They are particularly known for their products in oncology and dermatology. The company has achieved significant progress in addressing unmet medical needs.
Novartis is a global healthcare company focused on discovering, developing and commercializing innovative medicines. They aim to improve and extend people’s lives by addressing significant unmet medical needs with a broad portfolio of pharmaceuticals, including treatments for oncology, immunology, and other therapeutic areas. With a commitment to ethical behavior and corporate responsibility, Novartis integrates ESG principles into its business practices.
Changing the way diseases are treated, Arrowhead pharmaceuticals uses innovative, scientific methods to discover, develop, and deliver therapies and solutions.
We are a premier research-intensive biopharmaceutical company delivering innovative health solutions. We focus on the prevention and treatment of diseases in people and animals through leading-edge science. For over 130 years, we've developed important medicines and vaccines, aiming to save and improve lives globally. We foster inclusivity for a safe, sustainable future.
Yakult Honsha Co., Ltd. is a global company focused on contributing to the health and happiness of people around the world. They are best known for their probiotic dairy products, especially Yakult, a fermented milk drink containing *Lactobacillus casei* strain Shirota. Additionally, they offer a range of other food products, cosmetics, and pharmaceuticals, with a strong emphasis on research and development.
Regeneron is a biopharmaceutical company driven by scientific breakthroughs to create life-changing medicines for people with serious diseases. They focus on innovative solutions from biologics to genetic medicines. Their efforts redefine excellence and efficiency in research and development.
GSK unites science, technology, and talent to get ahead of disease. They focus on research and development within therapeutic areas like respiratory, immunology, oncology, and HIV. The company has a strong global presence and is committed to improving access to healthcare.
Novo Nordisk is a global healthcare company focused on discovering and developing innovative medicines to help people living with serious chronic diseases, primarily diabetes and obesity. They offer a range of pharmaceutical products and devices, including insulin and GLP-1 receptor agonists. Novo Nordisk holds a leading position in diabetes care and is committed to driving change to defeat other serious chronic conditions.
BioNTech is a global immunotherapy powerhouse aspiring to translate science into survival. They focus on developing drugs for cancer and infectious diseases by harnessing the full potential of the immune system. BioNTech is dedicated to improving the health of people worldwide through fundamental research and development of immunotherapies and mRNA vaccines.
Alnylam Pharmaceuticals is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics. They develop and commercialize medicines for genetic diseases. Their key products target rare diseases. Alnylam is a leader in RNAi technology, with a growing portfolio of approved therapies.
Servier er en uafhængig, international farmaceutisk virksomhed, der fokuserer på terapeutiske fremskridt for patienter. De investerer betydeligt i forskning og udvikling, især inden for onkologi, kardiometabolisme og neurovidenskab. Servier er kendt for sin langsigtede vision og engagement i patienternes behov.
This company focuses on providing affordable and innovative medicines. Key areas include generics, API & services, innovative medicines, and consumer health solutions. They are expanding their portfolio through in-licensing and partnerships. The company aims to improve patient access to treatments and operate globally with a strong commitment to integrity and quality.
Kamada is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. It boasts a diverse portfolio of marketed products, a robust development pipeline, and industry-leading manufacturing capabilities. The company drives profitable growth from commercial activities and expertise in the plasma-derived biopharmaceutical market. Noteworthy products include GLASSIA®, KEDRAB®, CYTOGAM®, HEPAGAM B®, VARIZIG® and WINRHO®SDF.
KalVista Pharmaceuticals is dedicated to advancing science to improve the lives of individuals, with an initial focus on hereditary angioedema (HAE). They are developing orally-delivered small molecule medicines to transform the HAE treatment landscape and address unmet patient needs. Their goal is to make a meaningful difference for people living with HAE by offering new possibilities for disease management. KalVista's lead product is an oral on-demand treatment for HAE.